Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Curr Opin Nephrol Hypertens ; 32(4): 359-365, 2023 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-37074688

RESUMEN

PURPOSE OF REVIEW: Most kidney stones are composed of calcium, and the greatest risk factor for kidney stone formation is hypercalciuria. Patients who form kidney stones often have reduced calcium reabsorption from the proximal tubule, and increasing this reabsorption is a goal of some dietary and pharmacological treatment strategies to prevent kidney stone recurrence. However, until recently, little was known about the molecular mechanism that mediates calcium reabsorption from the proximal tubule. This review summarizes newly uncovered key insights and discusses how they may inform the treatment of kidney stone formers. RECENT FINDINGS: Studies examining claudin-2 and claudin-12 single and double knockout mice, combined with cell culture models, support complementary independent roles for these tight junction proteins in contributing paracellular calcium permeability to the proximal tubule. Moreover, a family with a coding variation in claudin-2 causing hypercalciuria and kidney stones have been reported, and reanalysis of Genome Wide Association Study (GWAS) data demonstrates an association between noncoding variations in CLDN2 and kidney stone formation. SUMMARY: The current work begins to delineate the molecular mechanisms whereby calcium is reabsorbed from the proximal tubule and suggests a role for altered claudin-2 mediated calcium reabsorption in the pathogenesis of hypercalciuria and kidney stone formation.


Asunto(s)
Calcio , Hipercalciuria , Cálculos Renales , Cálculos Renales/genética , Cálculos Renales/fisiopatología , Cálculos Renales/prevención & control , Cálculos Renales/terapia , Hipercalciuria/genética , Hipercalciuria/fisiopatología , Hipercalciuria/prevención & control , Hipercalciuria/terapia , Calcio/metabolismo , Humanos , Animales , Claudina-2/genética , Claudina-2/metabolismo , Claudinas/genética , Claudinas/metabolismo , Estudio de Asociación del Genoma Completo , Túbulos Renales Proximales/fisiopatología
2.
Artículo en Inglés, Español | MEDLINE | ID: mdl-31387688

RESUMEN

Hypoparathyroidism is the most common complication after total or completion thyroidectomy. It is defined as the presence of hypocalcemia accompanied by low or inappropriately normal parathyroid hormone (PTH) levels. Acute hypocalcemia is a potential lethal complication. Hypocalcemia treatment is based on endovenous or oral calcium supplements as well as oral calcitriol, depending on the severity of the symptoms. The risk of clinical hypocalcemia after bilateral thyroidectomy is considered very low if postoperative intact PTH decrease less than 80% with respect to preoperative levels. These patients could be discharged home without treatment, although this threshold may vary between institutions, and we recommend close surveillance in cases with increased risk (Graves disease, large goiters, reinterventions or evidence of parathyroid gland removal). Long-term treatment objectives are to control the symptoms and to keep serum calcium levels at the lower limit of the normal range, while preserving the calcium phosphate product and avoiding hypercalciuria.


Asunto(s)
Hipoparatiroidismo/etiología , Tiroidectomía/efectos adversos , Calcitriol/uso terapéutico , Calcio/sangre , Calcio/uso terapéutico , Enfermedad de Graves/cirugía , Humanos , Hipercalciuria/prevención & control , Hipercalciuria/terapia , Hiperfosfatemia/tratamiento farmacológico , Hiperfosfatemia/etiología , Hipocalcemia/etiología , Hipoparatiroidismo/tratamiento farmacológico , Hipoparatiroidismo/prevención & control , Cuidados Intraoperatorios , Glándulas Paratiroides/cirugía , Glándulas Paratiroides/trasplante , Hormona Paratiroidea/sangre , Cuidados Posoperatorios , Reimplantación
3.
J Pediatr Gastroenterol Nutr ; 58(4): 398-403, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24253367

RESUMEN

OBJECTIVES: Bone mineralisation in preterm infants is related to the supply of calcium (Ca) and phosphorus (P). We increased the amount of minerals in parenteral nutrition (PN) for preterm infants and evaluated postnatal Ca and P metabolism in relation to mineral and vitamin D (vitD) intake. METHODS: Preterm infants, included on their first day of life, received standard PN, providing a maximum Ca/P intake of 3/1.92 mmol · kg(-1) · day(-1) on day 3. Ca/P content of formula was 2.5/1.6 mmol/dL, and fortified human milk was 2.4/1.95 mmol/dL. PN supplied 80 IU · kg(-1) · day(-1) vitD. Formula and fortified human milk contained 200 IU/dL of vitD. During a 5-week period, serum concentrations and urinary excretion of Ca/P were registered and related to the intake of minerals and vitD. RESULTS: During 12 months, 79 infants (mean gestational age 29.8 ± 2.2 weeks, mean birth weight 1248 ± 371 g) were included. The recommended intake for minerals was achieved by day 5 and for vitD by 4 weeks. Infants developed hypercalcaemia, hypercalciuria, and hypophosphataemia during the first postnatal week, leading to the additional P supplementation in 49 infants. The renal tubular reabsorption of P was >95% until day 9 but decreased <70% after the second week. Alkaline phosphatase was normal at birth, increased to a maximum of 450 IU/L by day 14, and remained above the normal range for the remaining period. CONCLUSIONS: Parenteral intake of P appeared to be too low, leading to mineral imbalances in the early postnatal period, and vitD intake was also below recommendations.


Asunto(s)
Calcio/metabolismo , Recien Nacido Prematuro/metabolismo , Nutrición Parenteral , Fósforo/metabolismo , Vitamina D/administración & dosificación , Vitaminas/administración & dosificación , Fosfatasa Alcalina/sangre , Lactancia Materna , Calcio/administración & dosificación , Alimentos Fortificados , Homeostasis , Humanos , Hipercalcemia/sangre , Hipercalcemia/terapia , Hipercalciuria/terapia , Hipercalciuria/orina , Hipofosfatemia/sangre , Hipofosfatemia/terapia , Fórmulas Infantiles , Recién Nacido , Túbulos Renales/metabolismo , Leche Humana , Fósforo/administración & dosificación , Estudios Prospectivos , Factores de Tiempo
4.
Nihon Jinzo Gakkai Shi ; 54(8): 1197-202, 2012.
Artículo en Japonés | MEDLINE | ID: mdl-23387283

RESUMEN

We report a case of a 59-year old Japanese woman with short bowel syndrome, whose hypokalemia and hypocalcemia were successfully treated with magnesium (Mg) supplementation. Two years previously, she underwent Mile's operation for advanced rectal cancer, which could have been the cause of subsequent extensive resection of the small intestine by strangulation. After serial resection, she gradually developed chronic diarrhea and anorexia. Three weeks before admission, she developed general fatigue and tetany, and was hospitalized at another hospital. On admission, her serum K and Ca were 2.5 mEq/L and 4.3 mg/dL, respectively, hence regular fluid therapy containing potassium (K) and calcium (Ca) was provided following admission. However, her hypokalemia and hypocalcemia persisted, and she also displayed renal dysfunction and thereafter was transferred to our department for further evaluation and treatment. Since the laboratory tests revealed severe hypomagnesemia (0.4 mg/dL), we started intravenous Mg supplementation together with fluid therapy containing K and Ca. After the combination therapy, her clinical symptoms and electrolyte disorders were remarkably improved within a week. As Mg is essential for PTH secretion in response to hypocalcemia and to inhibit the K channel activity that controls urinary K excretion, hypomagnesemia can cause hypocalcemia and hypokalemia, which is refractory to repletion therapy unless Mg is administered. Therefore, for patients who present with signs of Mg deficiency, early and accurate diagnosis of Mg deficiency should be made and corrected.


Asunto(s)
Hipercalciuria/etiología , Hipocalcemia/complicaciones , Hipopotasemia/complicaciones , Nefrocalcinosis/etiología , Defectos Congénitos del Transporte Tubular Renal/etiología , Síndrome del Intestino Corto/complicaciones , Femenino , Humanos , Hipercalciuria/metabolismo , Hipercalciuria/terapia , Hipocalcemia/diagnóstico , Hipocalcemia/terapia , Hipopotasemia/diagnóstico , Persona de Mediana Edad , Nefrocalcinosis/metabolismo , Nefrocalcinosis/terapia , Potasio/sangre , Defectos Congénitos del Transporte Tubular Renal/metabolismo , Defectos Congénitos del Transporte Tubular Renal/terapia , Síndrome del Intestino Corto/diagnóstico , Síndrome del Intestino Corto/metabolismo , Síndrome del Intestino Corto/terapia , Desequilibrio Hidroelectrolítico/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA